No Detail Found!

Causes and Risk Factors for Emergency Department Visits in Systemic Lupus Erythematosus: A Tertiary Center Study

Author(s)
Mohammad Mustafa Rheumatology Unit, Department of Medicine, University of Jeddah, Jeddah, Saudi Arabia
Albaraa Musallam Sufyani College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Omar Almazrouie College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Sami Bahlas Department of Internal Medicine/Rheumatology, College of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Bader Alsharif Rheumatology Unite, Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Yasser Bawazir Department of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Abstract
Objectives: Systemic Lupus Erythematosus (SLE) is associated with frequent Emergency Department (ED) utilization due to disease flares and comorbidities. However, data from Saudi Arabia and the Middle East remain limited. To describe the causes of ED visits among SLE patients and identify predictors of frequent ED visits (=2 visits/year) in a Saudi tertiary center. Methods: This retrospective cohort study included adult SLE patients presenting to the ED at King Abdulaziz University Hospital, Jeddah, Saudi Arabia, between January 2019 and December 2023. SLE was defined using 2019 EULAR/ACR criteria. Data on demographics, disease characteristics, comorbidities, laboratory parameters, treatment and medication adherence were collected. ED visit causes were categorized into musculoskeletal, gastrointestinal, infectious, neurological and cardiovascular groups. Logistic regression was used to identify predictors of frequent ED visits (=2 visits/year). Results: A total of 288 patients were included (87.2% female; mean age 38.3 ± 12.5 years). The most common ED visit causes were musculoskeletal complaints (24.7%) and gastrointestinal disorders (21.5%), followed by infections (16.7%). Independent predictors of frequent ED visits (=2 visits/year) included younger age (OR 0.95, 95% CI 0.92-0.97; p<0.001), longer disease duration (OR 1.09, 95% CI 1.03-1.15; p = 0.002) and higher serum creatinine (OR 1.004, 95% CI 1.001-1.008; p = 0.025). Medication non-adherence was the strongest predictor (OR 6.45; p<0.001), while absence of glucocorticoid use (OR 2.03; p = 0.040) and gastrointestinal involvement (OR 2.87; p = 0.012) were also significant. Conclusion: frequent ED visits (=2 visits/year) in SLE was associated with younger age, longer disease duration, renal impairment and medication non-adherence. Improving adherence and strengthening early outpatient management may help reduce avoidable ED visits.
Publication Details
Page(s) 110-114
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 5, Year: 2026

Request the full text from PASTIC

Keywords
Systemic lupus erythematosus, Predictors, Adherence, Emergency department, comorbidities, tertiary care
References
Sticherling M.,Kuhn A.,Braun-Falco's Dermatology A. .2023 .Systemic lupus erythematosus. , : 923-939.
Ameer M. .2022 .An overview of Systemic Lupus Erythematosus (SLE): pathogenesis, classification and management. ” Cureus, 14(10) : e30330.
Murimi-Worstell I.B. . .Healthcare utilization and costs of systemic lupus erythematosus by disease severity in the United States. ” Journal of Rheumatology, 48(2021) : 385-393.
Muñoz-Grajales C. . .Systemic lupus erythematosus and damage: What has changed over the past 20 years?” Best Practice and Research Clinical Rheumatology. , 37(2023) : 101893.
Feldman C.H. .2015 .Medication nonadherence and subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus. ” Arthritis Care and Research (Hoboken), 67(12) : 1712-1721.
Feldman C.H. . .Patterns and predictors of recurrent acute care use among Medicaid beneficiaries with systemic lupus erythematosus. ” Seminars in Arthritis and Rheumatism, 50(2020) : 1428-1436.
G.M. ,Han X.F. . .Comorbid conditions are associated with emergency department visits, hospitalizations and medical charges in systemic lupus erythematosus. ” Journal of Clinical Rheumatology, 23(2017) : 19-25.
Dhital R. .2023 .Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: NEDS analysis. ” Lupus, 32(14) : 1646-1655.
Lee J. .2019 .Persistently frequent emergency department utilization among persons with systemic lupus erythematosus. ” Arthritis Care & Research (Hoboken), 71(11) : 1410-1418.
Panopalis P. . .Frequent use of the emergency department among persons with systemic lupus erythematosus. ” Arthritis Care and Research (Hoboken), 62(2010) : 401-408.
Chen Y. .2011 .Severe systemic lupus erythematosus in the emergency department: A retrospective single-center study. ” Clinical Rheumatology, 30(11) : 1463-1469.
Nagai Y. . .Characteristics and risk factors for an emergency department visit in patients with systemic lupus erythematosus. , 39(2019) : 1567-1573.
Anders H.J.,Weening J.J. . .Kidney disease in lupus is not always lupus nephritis. ” Arthritis Research and Therapy, 15(2013) : 108.
Kamen D.L. . .Environmental influences on systemic lupus erythematosus expression. ” Rheumatic Disease Clinics of North America, 40(2014) : 401-412.
Galoppini G. .2023 .Optimizing patient care: A systematic review of multidisciplinary approaches for systemic lupus erythematosus management. ” Journal of Clinical Medicine, 12(12) : .
Gerosa M. .2022 .“Long-term clinical outcome in systemic lupus erythematosus patients followed for more than 20 years: The SMiLE cohort. ” Journal of Clinical Medicine, 11(13) : .
Piga M. . .Telemedicine for patients with rheumatic diseases: a systematic review and meta-analysis. ” Journal of Clinical Medicine, 11(2022) : 634.
Sharma A. . .Telemedicine in rheumatology: A systematic review. ” Arthritis Care & Research (Hoboken), 73(2021) : 334-344.
AlShomar A. .2024 .Clinical characteristics of systemic lupus erythematosus in the Kingdom of Saudi Arabia. Saudi Medical Journal, : .
Alsuwayegh A.,Al-Ruthia Y. .2025 .“Unveiling the financial burden of systemic lupus erythematosus management in Saudi Arabia: insights from a single-center study. ” Healthcare, 13 : 3075.
Almaghlouth I. . .Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population. ” Lupus Science and Medicine, 11(2024) : e001158.
Ambrose N. .2016 .Differences in disease phenotype and severity in systemic lupus erythematosus across age groups. ” Lupus, 25(14) : 1542-1550.
Costedoat-Chalumeau N. . .Adherence to treatment in systemic lupus erythematosus. ” Best Practice and Research Clinical Rheumatology, 27(2013) : 329-340.
0

Citations

0

Downloads

18

Views